Epoprostenol for Injection
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Pharmalucence, Inc.
- Effective date
- 2020-07-13
- Label type
- Human Prescription Drug Label
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:09:13
Label at a glance#
Label contents#
Full prescribing information#
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 0.5 ng Carton
Unapproved
NDC 62756-175-40
Epoprostenol for Injection
0.5 mg (500,000 ng)/vial
For Intravenous Infusion Only
Sterile, Lyophilized Product
1 x 10 mL Single-dose Vial
Discard Unused Portion
Rx only
Sun Pharma
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 1.5 ng Label
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 1.5 ng Carton
Unapproved
NDC 62756-176-40
Epoprostenol for Injection
1.5 mg (1,500,000 ng)/vial
For Intravenous Infusion Only
Sterile, Lyophilized Product
1 x 10 mL Single-dose Vial
Discard Unused Portion
Rx only
Sun Pharma
Products#
Every source-derived product name is available through these pages.
- epoprostenol
- EPOPROSTENOL SODIUM
- SUCROSE
- GLYCINE
- SODIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62756-175 | 62756-175-40 |
| 62756-176 | 62756-176-40 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EPOPROSTENOL SODIUM | 4K04IQ1OF4 | ACTIM |
| SUCROSE | C151H8M554 | IACT |
| GLYCINE | TE7660XO1C | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| EPOPROSTENOL SODIUM | 4K04IQ1OF4 | ACTIM |
| SUCROSE | C151H8M554 | IACT |
| GLYCINE | TE7660XO1C | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 552bc0c8-3255-4bec-98d1-9c36579c6f9e | d5fea1b5-69df-45a7-9753-a2f77eaa4cfd | 2021-01-29 | d5fea1b5-69df-45a7-9753-a2f77eaa4cfd |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



